Hex-1-yne-1,6-diol | 143672-70-2

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: Hex-1-yne-1,6-diol
• CAS: 143672-70-2
• 化学式: C₆H₁₀O₂
• 分子量: 114.14
• InChiKey: KNPAJOJKZPABSC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  8
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  40.5
• 氢给体数：
  2
• 氢受体数：
  2

文献信息

• Internal release agent, composition including internal release agent, and process for producing a plastic lens using same composition
  申请人：MITSUI CHEMICALS, INC.

  公开号：US10239239B2

  公开（公告）日：2019-03-26

  An internal release agent includes at least one phosphodiester represented by the following general formula (1). In the formula, R1 and R2 independently represent a hydrocarbon group having 1 to 30 carbon atoms, which is optionally substituted with at least one hydroxyl group, and R3 represents an alkylene group having 2 to 4 carbon atoms. A plurality of R3's may be the same as or different from each other. M represents a hydrogen atom, an ammonium ion, an alkali metal ion, or a monovalent/divalent alkali earth metal ion, and n is an integer of 1 to 60.

  内部释放剂至少包括一个由以下一般式（1）表示的磷酸二酯。在该式中，R1和R2分别表示具有1至30个碳原子的烃基，该烃基可以选择性地取代至少一个羟基，而R3表示具有2至4个碳原子的烷基基团。多个R3可以相同或者彼此不同。M代表氢原子、铵离子、碱金属离子或者一价/二价碱土金属离子，n为1至60的整数。
• Antithrombotic amides
  申请人：——

  公开号：US20030191153A1

  公开（公告）日：2003-10-09

  This application relates to a compound of formula I (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.

  该申请涉及公式I化合物（或其药学上可接受的盐），其制药组合物，以及其作为Xa因子抑制剂的用途，以及其制备过程和中间体。
• Biosynthetic uses of thermostable proteases
  申请人：GENEX CORPORATION (a Delaware corporation)

  公开号：EP0380362A1

  公开（公告）日：1990-08-01

  The invention relates to the novel use of mutants of subtilisin in organic syntheses reactions in non-native environments. Especially the invention relates to methods for the use of mutant subtilisins in organic solvents for the catalysis of reactions involving ester formation and cleavage, including acylations and deacylations, and amidations and deamidations. The methods provide novel strategies which are useful in the synthesis of deoxynucleosides, dideoxynucleosides, peptides, sugars and the like.

  本发明涉及在非原生环境中将突变体枯草蛋白用于有机合成反应的新方法。特别是本发明涉及在有机溶剂中使用突变体枯草蛋白催化酯形成和裂解反应的方法，包括酰化和脱酰化以及酰胺化和脱氨。这些方法提供了有助于合成脱氧核苷、双脱氧核苷、肽、糖等的新策略。
• Diol lipid analogues as edible fat replacements
  申请人：NABISCO, INC.

  公开号：EP0405874A1

  公开（公告）日：1991-01-02

  Diol lipid analogues, notably fatty acid diesters of various dihydric alcohols containing 4 to 10 carbon atoms, are physiologically compatible fat replacements in foods and pharmaceuticals. Preferred compounds are partially diges­tible.

  二元醇脂质类似物，特别是含有 4 至 10 个碳原子的各种二元醇的脂肪酸二酯，是食品和药品中生理上兼容的脂肪替代物。首选化合物可部分消化。
• New packaging/containerisation system for liquids
  申请人：RHONE-POULENC AGROCHIMIE

  公开号：EP0522713A1

  公开（公告）日：1993-01-13

  A containerisation system which comprises a concentrated hazardous and liquid composition in a cold water soluble or water dispersible bag wherein the bag has a residual inflatability. The hazardous composition comprises especially an agrochemical.

  一种容器化系统，包括装在冷水可溶袋或水分散袋中的浓缩危险液体成分，其中袋子具有剩余充气性。危险成分尤其包括农用化学品。